Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials

被引：112

作者：

Marty, Francisco M.

Lowry, Colleen M.

Lempitski, Steven J.

Kubiak, David W.

Finkelman, Malcolm A.

Baden, Lindsey R.

机构：

[1] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA 02115 USA

[4] Associates Cape Cod Inc, E Falmouth, MA USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2006年 / 50卷 / 10期

关键词：

D O I：

10.1128/AAC.00658-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Forty-four intravenous antimicrobials were tested for the presence of (1 -> 3)-beta-D-glucan (BG). Colistin, ertapenem, cefazolin, trimethoprim-sulfamethoxazole, cefotaxime, cefepime, and ampicillin-sulbactam tested positive for BG at reconstituted-vial concentrations but not when diluted to usual maximum plasma concentrations. False-positive BG assays may occur when some antimicrobials are administered; however, this needs to be confirmed.

引用

收藏

页码：3450 / 3453

页数：4

相关论文

共 18 条

[1] Detection of Aspergillus galactomannan antigen in foods and antibiotics [J].

Ansorg, R ;

van den Boom, R ;

Rath, PM .

MYCOSES, 1997, 40 (9-10) :353-357

[2]

*FDA, 2003, BIOR LAB PLAT ASP EI

[3]

*FDA, 2004, GLUC 1 3 BET D GLUC

[4] FALSE-POSITIVE RESULT IN LIMULUS TEST CAUSED BY LIMULUS AMEBOCYTE LYSATE-REACTIVE MATERIAL IN IMMUNOGLOBULIN PRODUCTS [J].

IKEMURA, K ;

IKEGAMI, K ;

SHIMAZU, T ;

YOSHIOKA, T ;

SUGIMOTO, T .

JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (09) :1965-1968

[5] Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level [J].

Kanda, H ;

Kubo, K ;

Hamasaki, K ;

Kanda, Y ;

Nakao, A ;

Kitamura, T ;

Fujita, T ;

Yamamoto, K ;

Mimura, T .

KIDNEY INTERNATIONAL, 2001, 60 (01) :319-323

[6] CLINICAL AND EXPERIMENTAL STUDIES OF THE LIMULUS TEST AFTER DIGESTIVE SURGERY [J].

KIMURA, Y ;

NAKAO, A ;

TAMURA, E ;

TANAKA, S ;

TAKAGI, H .

SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1995, 25 (09) :790-794

[7] Galactomannan in piperacillin-tazobactam: How much and to what extent? [J].

Machetti, M ;

Furfaro, E ;

Viscoli, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) :3984-3985

[8] 1,3-β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid [J].

Mennink-Kersten, Monique A. S. H. ;

Warris, Adilia ;

Verweij, Paul E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26) :2834-2835

[9] Experimental proof of contamination of blood components by (1→3)-β-D-glucan caused by filtration with cellulose filters in the manufacturing process [J].

K. Nagasawa ;

T. Yano ;

G. Kitabayashi ;

H. Morimoto ;

Y. Yamada ;

A. Ohata ;

M. Usami ;

T. Horiuchi .

Journal of Artificial Organs, 2003, 6 (1) :49-54

[10] β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome [J].

Odabasi, Z ;

Mattiuzzi, G ;

Estey, E ;

Kantarjian, H ;

Saeki, F ;

Ridge, RJ ;

Ketchum, PA ;

Finkelman, MA ;

Rex, JH ;

Ostrosky-Zeichner, L .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :199-205